AbbVie 2013 Annual Report Download - page 123

Download and view the complete annual report

Please find page 123 of the 2013 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 176

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176

13NOV201221365766
PROXY STATEMENT
Table of Contents
Solicitation of Proxies ........................................................ 1
Information about the Annual Meeting ............................................ 1
Who Can Vote ............................................................ 1
Notice and Access .......................................................... 1
Voting by Proxy ............................................................ 1
Revoking a Proxy .......................................................... 1
Discretionary Voting Authority .................................................. 1
Quorum and Vote Required to Approve Each Item on the Proxy .......................... 2
Effect of Broker Non-Votes and Abstentions ........................................ 2
Inspectors of Election ....................................................... 2
Cost of Soliciting Proxies ..................................................... 2
AbbVie Savings Plan ........................................................ 2
Separation of AbbVie from Abbott Laboratories ..................................... 3
Corporate Governance Materials ................................................ 3
Information Concerning Director Nominees (Item 1 on Proxy Card) ...................... 4
The Board of Directors and its Committees ........................................ 9
Communicating with the Board of Directors ........................................ 11
Director Compensation ....................................................... 12
Securities Ownership ......................................................... 14
Executive Compensation ...................................................... 16
Compensation Discussion and Analysis ........................................... 16
Stock Ownership Guidelines and Anti-Hedging and Anti-Pledging Policies ................... 26
Compensation Committee Report ............................................... 26
Compensation Risk Assessment ................................................ 26
Summary Compensation Table ................................................. 28
2013 Grants of Plan-Based Awards .............................................. 31
2013 Outstanding Equity Awards at Fiscal Year-End .................................. 33
2013 Option Exercises and Stock Vested .......................................... 36
Pension Benefits ........................................................... 36
2013 Nonqualified Deferred Compensation ........................................ 40
Potential Payments upon Termination or Change in Control ............................. 40
Ratification of Ernst & Young LLP as AbbVie’s Independent Registered Public Accounting Firm
(Item 2 on Proxy Card) ....................................................... 43
Audit Information ........................................................... 44
Audit Committee Report ...................................................... 46
Say on Pay—An Advisory Vote on the Approval of Executive Compensation (Item 3 on Proxy Card) .. 46
Procedures for Approval of Related Person Transactions ............................... 47
Additional Information ....................................................... 47
i